Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

A study to evaluate the prevalence of hypogonadism in Indian males with Type-2 diabetes mellitus.

Agarwal PK, Singh P, Chowdhury S, Sharma SK, Majumdar A, Shah P, Sahay R, Ayyar SV, Phatale H, Batra CM, Syed R, Shetty P.

Indian J Endocrinol Metab. 2017 Jan-Feb;21(1):64-70. doi: 10.4103/2230-8210.196008.

2.

Hormonal determinants of the severity of andropausal and depressive symptoms in middle-aged and elderly men with prediabetes.

Rabijewski M, Papierska L, Kuczerowski R, Piątkiewicz P.

Clin Interv Aging. 2015 Aug 20;10:1381-91. doi: 10.2147/CIA.S88499.

3.

Testosterone deficiency associated with poor glycemic control in korean male diabetics.

Kim JS, Kim BS, Jeon JY, Choi YJ, Chung YS.

Endocrinol Metab (Seoul). 2014 Sep;29(3):300-6. doi: 10.3803/EnM.2014.29.3.300.

4.

The role of hypogonadism in Klinefelter syndrome.

Høst C, Skakkebæk A, Groth KA, Bojesen A.

Asian J Androl. 2014 Mar-Apr;16(2):185-91. doi: 10.4103/1008-682X.122201. Review.

5.

Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.

Cai X, Tian Y, Wu T, Cao CX, Li H, Wang KJ.

Asian J Androl. 2014 Jan-Feb;16(1):146-52. doi: 10.4103/1008-682X.122346. Review.

6.
7.

The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer.

Gunter JH, Lubik AA, McKenzie I, Pollak M, Nelson CC.

Adv Urol. 2012;2012:248607. doi: 10.1155/2012/248607.

8.

Sex hormones, insulin resistance, and diabetes mellitus among men with or at risk for HIV infection.

Monroe AK, Dobs AS, Xu X, Palella FJ, Kingsley LA, Witt MD, Brown TT.

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):173-80. doi: 10.1097/QAI.0b013e3182278c09.

9.

Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men.

Lakshman KM, Bhasin S, Araujo AB.

J Gerontol A Biol Sci Med Sci. 2010 May;65(5):503-9. doi: 10.1093/gerona/glq002.

10.

Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes.

Perry JR, Weedon MN, Langenberg C, Jackson AU, Lyssenko V, Sparsø T, Thorleifsson G, Grallert H, Ferrucci L, Maggio M, Paolisso G, Walker M, Palmer CN, Payne F, Young E, Herder C, Narisu N, Morken MA, Bonnycastle LL, Owen KR, Shields B, Knight B, Bennett A, Groves CJ, Ruokonen A, Jarvelin MR, Pearson E, Pascoe L, Ferrannini E, Bornstein SR, Stringham HM, Scott LJ, Kuusisto J, Nilsson P, Neptin M, Gjesing AP, Pisinger C, Lauritzen T, Sandbaek A, Sampson M; MAGIC., Zeggini E, Lindgren CM, Steinthorsdottir V, Thorsteinsdottir U, Hansen T, Schwarz P, Illig T, Laakso M, Stefansson K, Morris AD, Groop L, Pedersen O, Boehnke M, Barroso I, Wareham NJ, Hattersley AT, McCarthy MI, Frayling TM.

Hum Mol Genet. 2010 Feb 1;19(3):535-44. doi: 10.1093/hmg/ddp522.

11.

The benefits and risks of testosterone replacement therapy: a review.

Bassil N, Alkaade S, Morley JE.

Ther Clin Risk Manag. 2009 Jun;5(3):427-48.

12.

Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.

Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, Morley JE, Schulman C, Thompson IM, Weidner W, Wu FC.

Eur J Endocrinol. 2008 Nov;159(5):507-14. doi: 10.1530/EJE-08-0601. No abstract available.

13.

Testosterone for the aging male; current evidence and recommended practice.

Stanworth RD, Jones TH.

Clin Interv Aging. 2008;3(1):25-44. Review.

Supplemental Content

Support Center